Beta Bionics (BBNX) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for Beta Bionics (BBNX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||
Total Revenue | 28M (-13.98%) | 32M (+17.87%) | 27M (+17.25%) | 23M (+31.75%) | 18M (-13.70%) | 20M (+22.40%) | 17M (+10.96%) | 15M (+16.40%) | 13M |
Gross Profit | 16M (-13.20%) | 19M (+25.26%) | 15M (+20.96%) | 13M (+39.35%) | 8.97M (-23.27%) | 12M (+31.20%) | 8.91M (+10.27%) | 8.08M (+12.22%) | 7.20M |
Operating Expenses | |||||||||
Research And Development | 10M (+2.27%) | 10M (+23.54%) | 8.20M (-7.55%) | 8.87M (+16.86%) | 7.59M (-17.59%) | 9.21M (+79.18%) | 5.14M (-19.06%) | 6.35M (+15.88%) | 5.48M |
Selling General And Administrative | 9.62M (+11.86%) | 8.60M (+8.59%) | 7.92M (+0.51%) | 7.88M (+19.03%) | 6.62M (+40.55%) | 4.71M (-7.83%) | 5.11M (+12.56%) | 4.54M (+29.34%) | 3.51M |
Operating Expenses | 41M (+16.08%) | 35M (+9.05%) | 32M (-0.68%) | 32M (+17.28%) | 28M (+11.65%) | 25M (+24.33%) | 20M (+0.10%) | 20M (+19.34%) | 17M |
Depreciation And Amortization | 590K (-53.54%) | 1.27M | - | - | 300K (-65.12%) | 860K | - | - | 290K |
Operating Income | |||||||||
Operating Income | -24.27M (+50.56%) | -16.12M (-5.40%) | -17.04M (-14.24%) | -19.87M (+6.60%) | -18.64M (+42.94%) | -13.04M (+18.76%) | -10.98M (-6.79%) | -11.78M (+24.66%) | -9.45M |
Ebit | -24.27M (+50.56%) | -16.12M (-5.40%) | -17.04M (-14.24%) | -19.87M (+6.60%) | -18.64M (+42.94%) | -13.04M (+18.76%) | -10.98M (-6.79%) | -11.78M (+24.66%) | -9.45M |
EBITDA | -23.69M (+14.50%) | -20.69M (+45.60%) | -14.21M (-15.77%) | -16.87M (-8.02%) | -18.34M (+70.92%) | -10.73M (+10.16%) | -9.74M (-32.64%) | -14.46M (+57.69%) | -9.17M |
Other Income / Expenses | |||||||||
Interest Income | 2.38M (-10.53%) | 2.66M (-6.01%) | 2.83M (-5.98%) | 3.01M (+23.36%) | 2.44M (+156.84%) | 950K (+14.46%) | 830K (-16.16%) | 990K (-13.16%) | 1.14M |
Net Interest Income | 2.38M (-10.53%) | 2.66M (-6.01%) | 2.83M (-5.98%) | 3.01M (+23.36%) | 2.44M (+156.84%) | 950K (+14.46%) | 830K (-16.16%) | 990K (-13.16%) | 1.14M |
Other Non Operating Income | 2.38M | - | - | - | - | - | - | - | - |
Net Income | |||||||||
Net Income From Continuing Operations | -21.89M (+62.51%) | -13.47M (-5.21%) | -14.21M (-15.77%) | -16.87M (-41.14%) | -28.66M (+58.26%) | -18.11M (+85.93%) | -9.74M (-32.64%) | -14.46M (+16.14%) | -12.45M |
Net Income | -21.89M (+62.51%) | -13.47M (-5.21%) | -14.21M (-15.77%) | -16.87M (-41.14%) | -28.66M (+58.26%) | -18.11M (+85.93%) | -9.74M (-32.64%) | -14.46M (+16.14%) | -12.45M |
Comprehensive Income Net Of Tax | -22.39M (-69.27%) | -72.86M (+420.43%) | -14.00M (-17.45%) | -16.96M (-40.45%) | -28.48M (-48.06%) | -54.83M (+467.60%) | -9.66M (-33.33%) | -14.49M (+15.18%) | -12.58M |